{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:46:09Z","timestamp":1786121169185,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011773","name":"Bourgogne-Franche-Comte Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijrobp.2026.06.3061","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:34:35Z","timestamp":1782516875000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["External Beam Radiation Therapy Primes Programmed Death-Ligand 1, Targeted Radionuclide Therapy in Preclinical Colorectal Cancer Model"],"prefix":"10.1016","author":[{"given":"Pierre-Simon","family":"Bellaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Ladjohounlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Claron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Froidurot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Denat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Truc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Cochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Baude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0047-9421","authenticated-orcid":false,"given":"C\u00e9line","family":"Mirjolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0002","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.radonc.2018.06.035","article-title":"Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review","volume":"129","author":"Petrelli","year":"2018","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0003","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2967\/jnumed.124.267452","article-title":"Dosimetry of [(177)Lu]Lu-PSMA-targeted radiopharmaceutical therapies in patients with prostate cancer: A comparative systematic review and metaanalysis","volume":"65","author":"Ells","year":"2024","journal-title":"J Nucl Med."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0004","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2967\/jnumed.123.265763","article-title":"Lesion dosimetry for [(177)Lu] Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer","volume":"64","author":"Grkovski","year":"2023","journal-title":"J Nucl Med."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.clon.2021.09.004","article-title":"Combining external beam radiation and radionuclide therapies: Rationale, radiobiology, results and roadblocks","volume":"33","author":"Abbott","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0006","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.trecan.2023.07.014","article-title":"Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors","volume":"9","author":"Pouget","year":"2023","journal-title":"Trends Cancer."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0007","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3390\/cells9092071","article-title":"Radiotherapy scheme effect on PD-L1 expression for locally advanced rectal cancer","volume":"9","author":"Boustani","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0008","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12967-025-06377-7","article-title":"Distinct immune responses to proton and photon radiotherapy: Implications for anti-PD-L1 combination therapy in colorectal cancer","volume":"23","author":"Burckel","year":"2025","journal-title":"J Transl Med."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/bs.mcb.2023.06.004","article-title":"Novel platform for subcutaneous tumor irradiation in mice","volume":"180","author":"Mirjolet","year":"2023","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40425-019-0634-9","article-title":"Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: A promising new combination","volume":"7","author":"Grapin","year":"2019","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/2040620717693574","article-title":"Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma","volume":"8","author":"Abuodeh","year":"2017","journal-title":"Ther Adv Hematol."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39543","article-title":"Targeted radionuclide therapy against GARP expressing t regulatory cells after tumour priming with external beam radiotherapy in a murine syngeneic model","volume":"10","author":"Bellaye","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1667\/RR2773.1","article-title":"Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS)","volume":"177","author":"Park","year":"2012","journal-title":"Radiat Res."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1440-1711.2003.01191.x","article-title":"Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty","volume":"81","author":"Murray","year":"2003","journal-title":"Immunol Cell Biol."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0016","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/acs.bioconjchem.7b00631","article-title":"Imaging PD-L1 expression with immunopet","volume":"29","author":"Truillet","year":"2018","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0017","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/0008-5472.CAN-15-2141","article-title":"Imaging, biodistribution, and dosimetry of radionuclide-labeled PD-L1 antibody in an immunocompetent mouse model of breast cancer","volume":"76","author":"Josefsson","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005060","article-title":"Antitumor efficacy of (90)y-nm 600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors","volume":"10","author":"Potluri","year":"2022","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0019","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2967\/jnumed.124.268586","article-title":"Pet imaging of PD-L1 occupancy for preclinical assessment of the efficacy of combined anti-PD-L1 immunotherapy and targeted therapy","volume":"66","author":"Chevaleyre","year":"2025","journal-title":"J Nucl Med."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0020","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.1021\/acsomega.9b03731","article-title":"Concurrent injection of unlabeled antibodies allows positron emission tomography imaging of programmed cell death ligand 1 expression in an orthotopic pancreatic tumor model","volume":"5","author":"Zhao","year":"2020","journal-title":"ACS Omega."},{"key":"10.1016\/j.ijrobp.2026.06.3061_bib0021","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2967\/jnumed.124.268857","article-title":"MHC-I-driven antitumor immunity counterbalances low absorbed doses of radiopharmaceutical therapy","volume":"66","author":"Constanzo","year":"2025","journal-title":"J Nucl Med."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626039167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626039167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:49:38Z","timestamp":1786070978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626039167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"alternative-id":["S0360301626039167"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.06.3061","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External Beam Radiation Therapy Primes Programmed Death-Ligand 1, Targeted Radionuclide Therapy in Preclinical Colorectal Cancer Model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.06.3061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}